Literature DB >> 22746695

Piperacillin/tazobactam-induced neutropenia, thrombocytopenia, and fever during treatment of a diabetic foot infection.

Günalp Uzun1, Yalçin Onem, Mustafa Hatipoglu, Vedat Turhan, Mesut Mutluoglu, Hakan Ay.   

Abstract

Piperacillin/tazobactam (PTZ) is frequently used in patients with diabetic foot infections. Herein, we report a patient who developed severe neutropenia, thrombocytopenia, and fever while receiving PTZ for a diabetic foot infection. We recommend vigilance when long-term PTZ use is planned in patients with diabetic foot infections.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22746695     DOI： 10.3109/00365548.2012.697638

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN： 0036-5548


  4 in total

1.  Risk of Neutropenia in Adults Treated with Piperacillin-Tazobactam or Cefazolin: A Retrospective Cohort Study.

Authors:  Marie-Pier Roy; Frédéric Calon; David Simonyan; Luc Bergeron
Journal:  Can J Hosp Pharm       Date:  2022-07-04

2.  Assessing the Effect of Piperacillin/Tazobactam on Hematological Parameters in Patients Admitted with Moderate or Severe Foot Infections.

Authors:  Will Fry; Sean McCafferty; Catherine Gooday; Ian Nunney; Ketan K Dhatariya
Journal:  Diabetes Ther       Date:  2018-01-04       Impact factor: 2.945

3.  Probable Vancomycin Induced Neutropenia: A Case Report.

Authors:  Anahat Kaur; Ghazal Khan; Punita Grover; Jill Moormeier
Journal:  Cureus       Date:  2019-07-22

4.  Tazobactam and piperacillin-induced thrombocytopenia: A case report.

Authors:  Hong Chen; Zhen Fan; Fei Guo; Yumin Yang; Jie Li; Jie Zhang; Yudan Wang; Jianwei LE; Zhiyu Wang; Jianhua Zhu
Journal:  Exp Ther Med       Date:  2016-02-09       Impact factor: 2.447
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.